Key points are not available for this paper at this time.
APRIL could be a potential biomarker for predicting difficult-to-treat cases of lupus nephritis.
Treamtrakanpon et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: